These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31824148)

  • 21. 2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor.
    Bazzi R; Bradshaw TD; Rowlands JC; Stevens MF; Bell DR
    Toxicol Appl Pharmacol; 2009 May; 237(1):102-10. PubMed ID: 19265716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivity.
    Hose CD; Hollingshead M; Sausville EA; Monks A
    Mol Cancer Ther; 2003 Dec; 2(12):1265-72. PubMed ID: 14707267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles.
    Leong CO; Suggitt M; Swaine DJ; Bibby MC; Stevens MF; Bradshaw TD
    Mol Cancer Ther; 2004 Dec; 3(12):1565-75. PubMed ID: 15634650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells.
    Brantley E; Patel V; Stinson SF; Trapani V; Hose CD; Ciolino HP; Yeh GC; Gutkind JS; Sausville EA; Loaiza-Pérez AI
    Anticancer Drugs; 2005 Feb; 16(2):137-43. PubMed ID: 15655410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy.
    Abuzaid H; Abdelrazig S; Ferreira L; Collins HM; Kim DH; Lim KH; Kam TS; Turyanska L; Bradshaw TD
    ACS Omega; 2022 Jun; 7(25):21473-21482. PubMed ID: 35785302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.
    Monks A; Harris E; Hose C; Connelly J; Sausville EA
    Mol Pharmacol; 2003 Mar; 63(3):766-72. PubMed ID: 12606787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities.
    Osmaniye D; Korkut Çelikateş B; Sağlık BN; Levent S; Acar Çevik U; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 210():112979. PubMed ID: 33183865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole.
    Loaiza-Pérez AI; Trapani V; Hose C; Singh SS; Trepel JB; Stevens MF; Bradshaw TD; Sausville EA
    Mol Pharmacol; 2002 Jan; 61(1):13-9. PubMed ID: 11752201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity.
    Petruk G; Monti DM; Ferraro G; Pica A; D'Elia L; Pane F; Amoresano A; Furrer J; Kowalski K; Merlino A
    ChemMedChem; 2019 Mar; 14(5):594-602. PubMed ID: 30674089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445).
    Bradshaw TD; Chua MS; Orr S; Matthews CS; Stevens MF
    Br J Cancer; 2000 Jul; 83(2):270-7. PubMed ID: 10901382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles.
    Bradshaw TD; Chua MS; Browne HL; Trapani V; Sausville EA; Stevens MF
    Br J Cancer; 2002 Apr; 86(8):1348-54. PubMed ID: 11953897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.
    Rowland LK; Campbell PS; Mavingire N; Wooten JV; McLean L; Zylstra D; Thorne G; Daly D; Boyle K; Whang S; Unternaehrer J; Brantley EJ
    J Cell Biochem; 2019 Apr; 120(4):6004-6014. PubMed ID: 30450577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.
    Bradshaw TD; Stevens MF; Westwell AD
    Curr Med Chem; 2001 Feb; 8(2):203-10. PubMed ID: 11172675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
    Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
    Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives.
    Shi DF; Bradshaw TD; Chua MS; Westwell AD; Stevens MF
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1093-5. PubMed ID: 11327598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity of Phortress against colorectal cancer.
    Mukherjee A; Martin SG
    Int J Oncol; 2006 Nov; 29(5):1287-94. PubMed ID: 17016663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?
    Bradshaw TD; Trapani V; Vasselin DA; Westwell AD
    Curr Pharm Des; 2002; 8(27):2475-90. PubMed ID: 12369945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity.
    Kang HJ; Kim HJ; Kwon SH; Kang BD; Eling TE; Lee SH; Bae I
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):689-97. PubMed ID: 18074135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.
    Bradshaw TD; Wrigley S; Shi DF; Schultz RJ; Paull KD; Stevens MF
    Br J Cancer; 1998 Mar; 77(5):745-52. PubMed ID: 9514053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoferritin as an ubiquitous nanocarrier with excellent shelf life.
    Dostalova S; Vasickova K; Hynek D; Krizkova S; Richtera L; Vaculovicova M; Eckschlager T; Stiborova M; Heger Z; Adam V
    Int J Nanomedicine; 2017; 12():2265-2278. PubMed ID: 28392686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.